Toggle navigation
Drugs
Combinations
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Blinded Bevacizumab
Combined with:
Blinded Placebo
Blinded Rituximab
Capecitabine
Cyclophosphamide
Doxorubicin Hcl
Prednisolone
Prednisone
Prednisone Tab
Rituxan
Rituximab
Vincristine
Indications and Reactions:
Role
Indications
Reactions
Primary
Drug Use For Unknown Indication
26.1%
Breast Cancer
21.1%
Diffuse Large B-cell Lymphoma
20.4%
Glioblastoma
5.4%
Breast Cancer Metastatic
5.3%
Prostate Cancer
3.6%
Ovarian Cancer
3.4%
Metastatic Malignant Melanoma
2.9%
Gastric Cancer
2.4%
Glioblastoma Multiforme
2.4%
Ovarian Epithelial Cancer
2.0%
Non-small Cell Lung Cancer
1.1%
Neoplasm Malignant
0.7%
Transitional Cell Carcinoma
0.7%
Fallopian Tube Cancer
0.6%
Metastatic Gastric Cancer
0.5%
Constipation
0.3%
Neuropathy Peripheral
0.3%
Ovarian Cancer Metastatic
0.3%
Pancreatic Carcinoma Metastatic
0.3%
Pyrexia
15.1%
Convulsion
14.0%
Anaemia
7.0%
Sepsis
7.0%
Small Intestinal Obstruction
7.0%
Sudden Death
4.7%
Vomiting
4.7%
Chest Pain
3.5%
Haemoglobin Decreased
3.5%
Peripheral Sensory Neuropathy
3.5%
Platelet Count Decreased
3.5%
Pneumonia
3.5%
Pneumonitis
3.5%
Pulmonary Oedema
3.5%
Splenic Abscess
3.5%
Thrombosis
3.5%
Acute Respiratory Distress Syndrome
2.3%
Atrial Fibrillation
2.3%
Bacteraemia
2.3%
Cerebral Ischaemia
2.3%
Secondary
Diffuse Large B-cell Lymphoma
50.4%
Drug Use For Unknown Indication
28.6%
Product Used For Unknown Indication
4.7%
Gastric Cancer
4.2%
Non-hodgkin's Lymphoma
2.6%
Breast Cancer Metastatic
2.0%
B-cell Lymphoma
1.8%
Breast Cancer
1.7%
Non-small Cell Lung Cancer
0.8%
Colorectal Cancer Metastatic
0.6%
Lymphoma
0.6%
Metastatic Renal Cell Carcinoma
0.5%
Metastatic Gastric Cancer
0.4%
Glioblastoma
0.2%
Multiple Myeloma
0.2%
Nausea
0.1%
Pain
0.1%
Premedication
0.1%
Glioblastoma Multiforme
0.1%
Hodgkin's Disease
0.1%
Febrile Neutropenia
35.9%
Neutropenia
8.6%
Pneumonia Aspiration
7.3%
Pyrexia
4.7%
Pneumonia
4.2%
Pulmonary Embolism
4.2%
Respiratory Failure
4.2%
Mucosal Inflammation
3.3%
Septic Shock
3.3%
White Blood Cell Count Decreased
3.1%
Gastric Perforation
2.9%
Upper Gastrointestinal Haemorrhage
2.9%
Hypokalaemia
2.2%
Rectal Ulcer
2.2%
Ascites
2.0%
Stomatitis
2.0%
Blood Sodium Decreased
1.8%
Convulsion
1.8%
Neutropenic Sepsis
1.8%
Laboratory Test Abnormal
1.6%
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Drug Data
Drugs
Combinations